Literature DB >> 1406270

The stable BRP signal peptide causes lethality but is unable to provoke the translocation of cloacin DF13 across the cytoplasmic membrane of Escherichia coli.

F J van der Wal1, B Oudega, M M Kater, C M ten Hagen-Jongman, F K de Graaf, J Luirink.   

Abstract

The bacteriocin release protein (BRP) mediates the secretion of cloacin DF13. The BRP precursor is slowly processed to yield the mature BRP and its stable signal peptide which is also involved in cloacin DF13 secretion. The function of the stable BRP signal peptide was analysed by constructing two plasmids. First, the stable BRP signal peptide was fused to the murein lipoprotein and, second, a stop codon was introduced after the BRP signal sequence. Exchange of the unstable murein lipoprotein signal peptide for the stable BRP signal peptide resulted in an accumulation of precursors of the hybrid murein lipoprotein. This indicated that the BRP signal peptide, as part of this hybrid precursor, is responsible for the slow processing. The stable BRP signal peptide itself was not able to direct the transfer of cloacin DF13 into the periplasmic space or into the culture medium. Over-expression of the BRP signal peptide was lethal and caused 'lysis'. Subcellular fractionation experiments revealed that the BRP signal peptide is located exclusively in the cytoplasmic membrane whereas the mature BRP, targeted by either the stable BRP signal peptide or the unstable Lpp signal peptide, is located in both the cytoplasmic and outer membrane. These results are in agreement with the hypothesis that the stable signal peptide and the mature BRP together are required for the passage of cloacin DF13 across the cell envelope.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1406270     DOI: 10.1111/j.1365-2958.1992.tb01406.x

Source DB:  PubMed          Journal:  Mol Microbiol        ISSN: 0950-382X            Impact factor:   3.501


  8 in total

Review 1.  Membrane proteases in the bacterial protein secretion and quality control pathway.

Authors:  Ross E Dalbey; Peng Wang; Jan Maarten van Dijl
Journal:  Microbiol Mol Biol Rev       Date:  2012-06       Impact factor: 11.056

2.  Expression of the pCloDF13 encoded bacteriocin release protein or its stable signal peptide causes early effects on protein biosynthesis and Mg2+ transport.

Authors:  F Stegehuis; F J van der Wal; J Luirink; B Oudega
Journal:  Antonie Van Leeuwenhoek       Date:  1995       Impact factor: 2.271

3.  Escherichia coli SecB, SecA, and SecY proteins are required for expression and membrane insertion of the bacteriocin release protein, a small lipoprotein.

Authors:  B Oudega; O Mol; P van Ulsen; F Stegehuis; F J van der Wal; J Luirink
Journal:  J Bacteriol       Date:  1993-03       Impact factor: 3.490

4.  Comprehensive characterization of methicillin-resistant Staphylococcus aureus subsp. aureus COL secretome by two-dimensional liquid chromatography and mass spectrometry.

Authors:  Shobha Ravipaty; James P Reilly
Journal:  Mol Cell Proteomics       Date:  2010-04-24       Impact factor: 5.911

5.  In vivo analysis of sequence requirements for processing and degradation of the colicin A lysis protein signal peptide.

Authors:  S P Howard; L Lindsay
Journal:  J Bacteriol       Date:  1998-06       Impact factor: 3.490

6.  Posttranscriptional repression of the cel gene of the ColE7 operon by the RNA-binding protein CsrA of Escherichia coli.

Authors:  Tsung-Yeh Yang; Yun-Min Sung; Guang-Sheng Lei; Tony Romeo; Kin-Fu Chak
Journal:  Nucleic Acids Res       Date:  2010-04-08       Impact factor: 16.971

7.  A fitness cost associated with the antibiotic resistance enzyme SME-1 beta-lactamase.

Authors:  David C Marciano; Omid Y Karkouti; Timothy Palzkill
Journal:  Genetics       Date:  2007-06-11       Impact factor: 4.562

Review 8.  Colicin biology.

Authors:  Eric Cascales; Susan K Buchanan; Denis Duché; Colin Kleanthous; Roland Lloubès; Kathleen Postle; Margaret Riley; Stephen Slatin; Danièle Cavard
Journal:  Microbiol Mol Biol Rev       Date:  2007-03       Impact factor: 11.056

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.